secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001380106-25-000169
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q2 revenue $7.3M (+10% YoY); enters $45M term loan with Trinity Capital
--------------------------------------------------------------------------------

- Q2 2025 revenue $7.3M, up 10% YoY; net loss $11.9M ($0.27/sh) vs $12.6M ($0.29) prior year.
- Gross margin turned positive at 4% (vs -3% in Q2 2024); recurring revenue up 15% to $4.4M.
- Reaffirms FY2025 revenue guidance of at least $32.0M.
- Entered $45M term loan facility with Trinity Capital; $20M drawn at close, no financial covenants.
- Initial interest rate 11.5% p.a.; 36-month interest-only period; warrants for 179,104 shares at $3.35/sh.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000169/0001380106-25-000169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000169/rpid-20250808.htm
  HTML page:      https://secwatch.observer/filing/0001380106-25-000169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer